Skip to main content
Clinical Trials/ACTRN12622000239763
ACTRN12622000239763
Active, not recruiting
未知

A three-arm cluster randomised controlled trial of the QuikFix Alcohol and Other Drug (AOD) harm minimisation workshop and targeted brief intervention on alcohol and other drug use among residential college students.

The University of Queensland0 sites556 target enrollmentFebruary 10, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
The University of Queensland
Enrollment
556
Status
Active, not recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 10, 2022
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Pre\-intervention baseline \- QuikFix Alcohol and Other Drug (AOD) harm reduction workshop:
  • Those aged 17 \+ years who provide consent to participate in the research and complete the baseline survey will be eligible to participate in the evaluation. All first years at colleges allocated to Groups 1 and 2 will be able to attend the workshop regardless of their consent to participate in the research.
  • QuikFix Brief AOD Intervention:
  • Only socially influential first year students identified as risky drinkers at the colleges assigned to Group 2 (i.e., workshop \+ QuikFix) will be eligible to receive the QuikFix Brief Telehealth Intervention. Socially Influential first years will be identified using the first year cohorts’ responses to an adapted version of the Important People Instrument administered at 6\-weeks post baseline (Clifford \& Longabaugh, 1991\).
  • Risky drinking is defined as consumption of 4 (if female) or 5 (if male) standard drinks on greater than or equal to 2 occasions in the past month (30 days; Barnett, 2019\). Users of illicit drugs including cannabis will be eligible to receive QuikFix, as long as alcohol is the most frequently used drug (other than tobacco).

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials